| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1210332B1 Bleach boosting components, compositions and laundry methods |
| 05/31/2006 | CN1780663A 9-azabicyclo nonylene derivatives with a heteroatom at the 3-position as renin inhibitors |
| 05/31/2006 | CN1780624A Tetracyclic benzamide derivatives and methods of use thereof |
| 05/31/2006 | CN1778800A Chiral piperazine substrated quinolone carboxylic acid derivative, and preparation and use thereof |
| 05/31/2006 | CN1257908C Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 05/31/2006 | CN1257895C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/30/2006 | US7053219 such as 5-methyl-6-(4-methoxyphenyl)-3-pyridin-4-yl-isoxazolo[4,5-c]pyridin-4(5H)one which has metabotropic glutamic acid receptor-antagonistic effect; for treatment of anxiety disorders, psychosomatic disorders, and eating disorders |
| 05/30/2006 | US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 05/30/2006 | US7053102 A beta -hydroxylactone replaces the natural alpha -hydroxylactone of camptothecin; for treating colon and breast cancer |
| 05/30/2006 | CA2237594C Fused imidazole derivatives as multidrug resistance modulators |
| 05/30/2006 | CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation |
| 05/26/2006 | WO2006054652A1 Amide compound |
| 05/26/2006 | CA2584619A1 Amide compound |
| 05/25/2006 | US20060111570 Antitumor agents; microbiocides; antibiotics; forming a 1,4 bridge using a 1-labile, 10-hydroxy, 18-protected hydroxyl, di-6,8-en-5-one fused ring compound. After formation of the 1,4 brige, C-18 protection is removed before spiroamine introduction |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111415 2-Aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111414 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111413 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111367 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 05/25/2006 | US20060111359 enzyme inhibitor for treating sleep disorders |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/24/2006 | EP1659114A2 Process for the preparation of bicyclo[3.2.1]octane fused with quinazoline derivatives |
| 05/24/2006 | EP1658295A2 Regioselective synthesis of cci-779 |
| 05/24/2006 | EP1658294A1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | CN1777612A New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 05/24/2006 | CN1775783A 2-tri fluoro methyl xazole (4, 5) pyridine and its preparing method |
| 05/24/2006 | CN1257170C Organic photochromic composite nano materials and method for preparing same |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049310 Therapy for bacteria infections |
| 05/18/2006 | WO2006052013A1 Thienopyrrole compounds and utilization thereof as hcv polymerase inhibitor |
| 05/18/2006 | WO2006050598A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/18/2006 | WO2005121151A3 Thienopyridinone compounds and methods of treatment |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | US20060106213 New Medicaments for the Treatment of Chronic Obstructive Pulmonary Disease |
| 05/18/2006 | US20060106212 6-halo-5-ulosonic acid ester with a 2-aminoalkanethiol form a thiazine ring; reduction and cyclization to form a lactam; reduction and deprotection; Selective alpha glycosidase inhibitors; rigidity of bicyclic ring; industrial scale; 1,5-dideoxy-1,5-imino functionality; glycosyltransferase inhibitors |
| 05/18/2006 | US20060106051 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/18/2006 | US20060106021 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma |
| 05/18/2006 | US20060106020 Tetracyclic inhibitors of Janus kinases |
| 05/18/2006 | US20060106013 PI3-kinases |
| 05/18/2006 | US20060106007 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide |
| 05/18/2006 | US20060105436 Immunosuppressant selected from prolyl-rapamycin, 4-hydroxy-prolyl-rapamycin, 4-hydroxyprolyl-26-demethoxy-rapamycin, 3-hydroxy-prolyl-rapamycin, 3-hydroxy-prolyl-26-demethoxy-rapamycin, and trans-3-aza-bicyclo[3,1,0]hexane-2-carboxylic acid rapamycin |
| 05/18/2006 | CA2585165A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/17/2006 | EP1656383A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |
| 05/17/2006 | EP1656382A2 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 05/17/2006 | EP1656372A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 05/17/2006 | EP1656140A1 Mitotic kinesin inhibitors |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | CN1774265A Drug for nerve regeneration |
| 05/17/2006 | CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation |
| 05/17/2006 | CN1256337C Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 05/17/2006 | CN1256328C Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/16/2006 | US7045620 Crystal structure antibiotic; heating, dissolving, crystallization |
| 05/11/2006 | WO2006050435A1 Heterocyclical chromophore architectures |
| 05/11/2006 | WO2006050170A2 Medical devices containing rapamycin analogs |
| 05/11/2006 | WO2006048296A1 Organic compounds |
| 05/11/2006 | WO2006048145A1 Process for the purification of tacrolimus |
| 05/11/2006 | WO2006018280A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/11/2006 | WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists |
| 05/11/2006 | US20060100431 Biologically active compounds |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100232 Inhibitors of HIV-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof |
| 05/11/2006 | US20060100231 Amorphous clopidogrel hydrogen sulfate |
| 05/11/2006 | US20060100221 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl) 1 methylethyl]amino]-thiazolo[4,5-d]pyrimidin-2(3H)-one; asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 05/11/2006 | US20060100215 8A,9-dihydro-4aH-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 05/11/2006 | US20060100197 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation |
| 05/11/2006 | US20060100194 Lactam compounds useful as protein kinase inhibitors |
| 05/11/2006 | CA2586193A1 Process for the purification of tacrolimus |
| 05/11/2006 | CA2584911A1 Crystalline and amorphous n-benzoyl-staurosporine |
| 05/11/2006 | CA2584869A1 Heterocyclical chromophore architectures |
| 05/10/2006 | EP1655372A2 Production of polyketides and other natural products |
| 05/10/2006 | EP1654264A1 Spiro [1-azabicyclo [2.2.2]octane-3,5'-oxazolidin-2'-one] derivatives with affinity to the alpha7 nicotinic acetylcholine receptor |
| 05/10/2006 | CN1255413C (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
| 05/10/2006 | CN1255412C 6íõ-heterocycle substituted spirooxazine photochromic compound and method for preparing same |
| 05/09/2006 | US7041819 Separation technology, environmental remediation, and biomedical applications such as dialysis and drug delivery |
| 05/09/2006 | US7041696 Induce inflammation, immunology response; autoimmune disease; antiarthritic agents |
| 05/09/2006 | US7041695 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | CA2257646C Benzo[g]quinoline derivatives |
| 05/04/2006 | WO2006047772A2 Tricyclic spacer systems for nonlinear optical devices |
| 05/04/2006 | WO2006047452A2 Reactive 1,3’-crosslinked carbocyanines and their bioconjugates |
| 05/04/2006 | WO2006045495A1 Photochromic h-annellated benzo[f]chrome-derivatives |
| 05/04/2006 | WO2006031661A3 Process for isolation of macrolide compounds |
| 05/04/2006 | WO2006021454A3 Pyrimidine derivatives |
| 05/04/2006 | US20060094767 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094743 Isoquinoline compounds and medicinal use thereof |
| 05/04/2006 | US20060094702 5-HT4 receptor antagonists |
| 05/04/2006 | CA2730374A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 05/04/2006 | CA2585847A1 Photochromic h-fused benzo[f]chromene derivatives |